LU81763A1 - Procede de preparation du sulfate de vindesine - Google Patents
Procede de preparation du sulfate de vindesine Download PDFInfo
- Publication number
- LU81763A1 LU81763A1 LU81763A LU81763A LU81763A1 LU 81763 A1 LU81763 A1 LU 81763A1 LU 81763 A LU81763 A LU 81763A LU 81763 A LU81763 A LU 81763A LU 81763 A1 LU81763 A1 LU 81763A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- vindesin
- sulfuric acid
- vindesine
- monosulfate
- acetonitrile
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 20
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 66
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 5
- 150000004683 dihydrates Chemical class 0.000 claims 1
- NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 23
- 229960004355 vindesine Drugs 0.000 description 23
- UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 23
- 238000006386 neutralization reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229960004528 vincristine Drugs 0.000 description 3
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 3
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 3
- KABRXLINDSPGDF-UHFFFAOYSA-N 7-bromoisoquinoline Chemical compound C1=CN=CC2=CC(Br)=CC=C21 KABRXLINDSPGDF-UHFFFAOYSA-N 0.000 description 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229960003048 vinblastine Drugs 0.000 description 2
- 229960005212 vindesine sulfate Drugs 0.000 description 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94959578A | 1978-10-10 | 1978-10-10 | |
| US94959578 | 1978-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU81763A1 true LU81763A1 (fr) | 1980-01-24 |
Family
ID=25489302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU81763A LU81763A1 (fr) | 1978-10-10 | 1979-10-08 | Procede de preparation du sulfate de vindesine |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0009996B1 (cs) |
| JP (1) | JPS5553295A (cs) |
| KR (1) | KR850000150B1 (cs) |
| AR (1) | AR225153A1 (cs) |
| AT (1) | AT370422B (cs) |
| AU (1) | AU525702B2 (cs) |
| BE (1) | BE879213A (cs) |
| BG (1) | BG34763A3 (cs) |
| CA (1) | CA1114817A (cs) |
| CH (2) | CH649301A5 (cs) |
| CS (1) | CS235503B2 (cs) |
| DD (1) | DD146461A5 (cs) |
| DE (1) | DE2964913D1 (cs) |
| DK (1) | DK146823C (cs) |
| EG (1) | EG14140A (cs) |
| ES (1) | ES484827A1 (cs) |
| FI (1) | FI70223C (cs) |
| FR (1) | FR2438659A1 (cs) |
| GB (1) | GB2031893B (cs) |
| GR (1) | GR72394B (cs) |
| HU (1) | HU180744B (cs) |
| IE (1) | IE48958B1 (cs) |
| IL (1) | IL58390A (cs) |
| LU (1) | LU81763A1 (cs) |
| MY (1) | MY8500569A (cs) |
| NZ (1) | NZ191744A (cs) |
| PH (1) | PH16092A (cs) |
| PL (1) | PL117678B1 (cs) |
| PT (1) | PT70269A (cs) |
| RO (1) | RO77380A (cs) |
| YU (1) | YU241179A (cs) |
| ZA (1) | ZA795268B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4558053A (en) * | 1983-12-21 | 1985-12-10 | Eli Lilly And Company | Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole alkaloids |
| CN112592357B (zh) * | 2020-12-22 | 2022-03-22 | 海南长春花药业有限公司 | 一种硫酸长春地辛的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL48685A (en) * | 1975-01-09 | 1980-03-31 | Lilly Co Eli | Amides of vincadioline and vinblastine |
| US4029663A (en) * | 1975-07-10 | 1977-06-14 | Eli Lilly And Company | Dimeric anhydro-vinca derivatives |
| GR69783B (cs) * | 1976-09-08 | 1982-07-07 | Lilly Co Eli |
-
1979
- 1979-10-02 AR AR278306A patent/AR225153A1/es active
- 1979-10-03 PT PT70269A patent/PT70269A/pt unknown
- 1979-10-03 AU AU51427/79A patent/AU525702B2/en not_active Expired
- 1979-10-03 CS CS796720A patent/CS235503B2/cs unknown
- 1979-10-03 FI FI793065A patent/FI70223C/fi not_active IP Right Cessation
- 1979-10-03 YU YU02411/79A patent/YU241179A/xx unknown
- 1979-10-03 NZ NZ191744A patent/NZ191744A/xx unknown
- 1979-10-03 ZA ZA00795268A patent/ZA795268B/xx unknown
- 1979-10-04 JP JP12879579A patent/JPS5553295A/ja active Granted
- 1979-10-04 CA CA336,959A patent/CA1114817A/en not_active Expired
- 1979-10-04 IL IL58390A patent/IL58390A/xx unknown
- 1979-10-05 FR FR7924841A patent/FR2438659A1/fr active Granted
- 1979-10-05 BE BE1/9554A patent/BE879213A/fr not_active IP Right Cessation
- 1979-10-05 PL PL1979218756A patent/PL117678B1/pl unknown
- 1979-10-06 RO RO7998873A patent/RO77380A/ro unknown
- 1979-10-08 BG BG045074A patent/BG34763A3/xx unknown
- 1979-10-08 ES ES484827A patent/ES484827A1/es not_active Expired
- 1979-10-08 LU LU81763A patent/LU81763A1/fr unknown
- 1979-10-08 CH CH691/84A patent/CH649301A5/fr not_active IP Right Cessation
- 1979-10-08 GR GR60215A patent/GR72394B/el unknown
- 1979-10-08 CH CH904479A patent/CH645120A5/fr not_active IP Right Cessation
- 1979-10-09 IE IE1914/79A patent/IE48958B1/en not_active IP Right Cessation
- 1979-10-09 EG EG590/79A patent/EG14140A/xx active
- 1979-10-09 AT AT0658279A patent/AT370422B/de not_active IP Right Cessation
- 1979-10-09 GB GB7935062A patent/GB2031893B/en not_active Expired
- 1979-10-09 DE DE7979302152T patent/DE2964913D1/de not_active Expired
- 1979-10-09 DK DK422979A patent/DK146823C/da not_active IP Right Cessation
- 1979-10-09 HU HU79EI881A patent/HU180744B/hu unknown
- 1979-10-09 EP EP79302152A patent/EP0009996B1/en not_active Expired
- 1979-10-10 DD DD79216158A patent/DD146461A5/de unknown
- 1979-10-10 KR KR7903467A patent/KR850000150B1/ko not_active Expired
-
1981
- 1981-02-03 PH PH25176A patent/PH16092A/en unknown
-
1985
- 1985-12-30 MY MY569/85A patent/MY8500569A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0078785B1 (fr) | Sels d'acide valproîque, leur préparation et leur utilisation | |
| EP0010458B1 (fr) | Composés bis-indoliques, compositions pharmaceutiques les contenant, procédé pour leur préparation | |
| CH639070A5 (fr) | 4-(di-n-propyl)amino-1,3,4,5-tetrahydrobenzo(cd)indole et composition pharmaceutique en contenant. | |
| LU83423A1 (fr) | Pneumatique radial pour vehicules tout-terrain | |
| FR2505185A1 (fr) | Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant | |
| EP0840720B1 (fr) | Prodede pour obtenir acides gras iodes et leurs derives par iodohydrination, faisant intervenir des derives alkylsilyles avec des iodures alcalins et leurs activites pharmacologiques | |
| LU81763A1 (fr) | Procede de preparation du sulfate de vindesine | |
| FR2616429A1 (fr) | Procede de preparation du 1,2,5,6,9,10-hexabromocyclododecane | |
| FR2650280A1 (fr) | (2r,cis)-1,2-epoxypropyl-phosphonate de mono-(2-ammonium-2-hydroxymethyl-1,3-propanediol) ayant des caracteristiques ameliorees de stabilite, son procede de preparation et compositions pharmaceutiques le contenant | |
| DE3443467A1 (de) | Mercaptanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate | |
| LU81684A1 (fr) | Procede d'elimination des sels de potassium des sous produits de distillation | |
| EP0396458A1 (fr) | Procédé de purification des trifluoromethanesulfinate et sulfonate de sodium | |
| EP0134729B1 (fr) | Procédé de préparation de globine à partir d'hémoglobine et globine obtenue par ce procédé | |
| EP0092287B1 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
| EP0117861B1 (fr) | Procédé d'obtention de la vincristine | |
| CH616918A5 (cs) | ||
| KR102305089B1 (ko) | 멍게체액 추출물의 제조방법 | |
| EP1664044B1 (fr) | Sel de sodium monohydrate du s-tenatoprazole et application en tant qu'inhibiteur de la pompe a protons | |
| EP2486019A1 (fr) | Procede de synthese de la 2-thiohistidine et analogues | |
| FR2647448A1 (fr) | Procede de preparation du (chloro-3 hydroxy-2 propyl)-1 methyl-2 nitro-5 imidazole | |
| CA1210762A (fr) | Methode de preparation de vincristine | |
| FR2582657A1 (fr) | Procede de preparation de sels d'heparine | |
| EP0017525B1 (fr) | Nouveaux dérivés tétrahydroalstoniques, leur préparation et leur application en tant que médicaments | |
| CH634571A5 (fr) | Procede de preparation d'un derive du thiophene et derive obtenu par ce procede. | |
| FR2616788A1 (fr) | Procede pour la fabrication d'esters du 1-methyl-10a-methoxy-lu milysergol |